MGTX
Common StockMeiraGTx Holdings plc
Reported Shares
12.2M
Position Mix
No options reported
Reported Value
$134.2M
Portfolio Weight
21.30%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$629.9M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
MGTX
Common StockMeiraGTx Holdings plc
Reported Shares
12.2M
Position Mix
No options reported
Reported Value
$134.2M
Portfolio Weight
21.30%
INBX
Common StockInhibrx Biosciences, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$115.9M
Portfolio Weight
18.40%
NVAX
Common StockNOVAVAX INC
Reported Shares
6.9M
Position Mix
No options reported
Reported Value
$74.4M
Portfolio Weight
11.81%
KRSA
Common StockKorsana Biosciences, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$63.8M
Portfolio Weight
10.13%
ODTX
Common StockOdyssey Therapeutics, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$44.2M
Portfolio Weight
7.02%
ANAB
Common StockANAPTYSBIO, INC
Reported Shares
821.9K
Position Mix
No options reported
Reported Value
$41.3M
Portfolio Weight
6.56%
AGMB
Depositary ReceiptAgomab Therapeutics NV
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$30.9M
Portfolio Weight
4.90%
TRAX
Common StockFirst Tracks Biotherapeutics, Inc.
Reported Shares
821.9K
Position Mix
No options reported
Reported Value
$29.1M
Portfolio Weight
4.62%
ETRA
Common StockElectra Therapeutics, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$27.7M
Portfolio Weight
4.40%
ATTO
Common StockAttovia Therapeutics, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$18.6M
Portfolio Weight
2.95%
LTGO
Common StockLatigo Biotherapeutics, Inc.
Reported Shares
672.8K
Position Mix
No options reported
Reported Value
$11.2M
Portfolio Weight
1.78%
IMRX
Common StockImmuneering Corp
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$11.1M
Portfolio Weight
1.76%
MPLT
Common StockMapLight Therapeutics, Inc.
Reported Shares
912K
Position Mix
No options reported
Reported Value
$9.3M
Portfolio Weight
1.48%
SCTX
Common StockScribe Therapeutics, Inc.
Reported Shares
500K
Position Mix
No options reported
Reported Value
$9.2M
Portfolio Weight
1.46%
SABS
Common StockSAB Biotherapeutics, Inc.
Reported Shares
2.2M
Position Mix
No options reported
Reported Value
$7.0M
Portfolio Weight
1.11%
QTTB
Common StockQ32 Bio Inc.
Reported Shares
244.1K
Position Mix
No options reported
Reported Value
$2.0M
Portfolio Weight
0.32%